Trial · NCT00935259
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Arachidonic Acid Level After 2 Weeks of Treatment | Simvastatin 40 mg | 259.1 | Standard Deviation 89.1 | nmol | |
| Arachidonic Acid Level After 2 Weeks of Treatment | Placebo | 269.6 | Standard Deviation 85.2 | nmol | |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Cholesterol ester lipid 16:00 | 288.9 | Standard Deviation 102.1 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Cholesterol ester lipid 16:00 | 345.1 | Standard Deviation 87.3 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Cholesterol ester lipid 18:3n3 | 10.0 | Standard Deviation 4.8 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Cholesterol ester lipid 18:3n3 | 14.4 | Standard Deviation 6.7 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Cholesterol ester lipid 20:3n6 | 20.9 | Standard Deviation 10.5 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Cholesterol ester lipid 20:3n6 | 23.5 | Standard Deviation 10.2 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Cholesterol ester lipid 20:3n9 | 1.3 | Standard Deviation 1.1 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Cholesterol ester lipid 20:3n9 | 1.2 | Standard Deviation 0.9 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Cholesterol ester lipid 22:5n6 | 1.0 | Standard Deviation 0.8 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Cholesterol ester lipid 22:5n6 | 1.1 | Standard Deviation 0.4 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Cholesterol ester lipid 22:6n3 | 12.7 | Standard Deviation 5.1 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Cholesterol ester lipid 22:6n3 | 14.8 | Standard Deviation 6.8 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Lysophosphatidyl-choline lipid 20:4n6 | 11.1 | Standard Deviation 3.8 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Lysophosphatidyl-choline lipid 20:4n6 | 10.3 | Standard Deviation 2.7 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Phosphatidyl-choline lipid 18:2n6 | 684.8 | Standard Deviation 224.9 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Phosphatidyl-choline lipid 18:2n6 | 824.9 | Standard Deviation 196.2 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Simvastatin 40 mg | Phosphatidyl-choline lipid 20:3n6 | 117.4 | Standard Deviation 54.3 | nmol |
| Fasting Blood Lipidomic Levels After 2 Weeks of Treatment | Placebo | Phosphatidyl-choline lipid 20:3n6 | 127.1 | Standard Deviation 58.8 | nmol |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00935259/results